CLEARVIEW WEALTH LIMITED (CVW)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

CVW - CLEARVIEW WEALTH LIMITED

FNArena Sector : Insurance
Year End: June
GICS Industry Group : Diversified Financials
Debt/EBITDA: 4.83
Index: ALL-ORDS

LAST PRICE CHANGE +/- CHANGE % VOLUME

$0.365

20 Dec
2024

-0.010

OPEN

$0.38

-2.67%

HIGH

$0.38

176,931

LOW

$0.37

TARGET
$0.58 58.9% upside
Franking for last dividend paid out: 100%
OTHER COMPANIES IN THE SAME SECTOR
AUB . FCL . GDG . HLI . IAG . MPL . NHF . NOL . QBE . SDF . SUN . TWR .
FNARENA'S MARKET CONSENSUS FORECASTS
CVW: 1
Title FY23
Actual		 FY24
Actual		 FY25
Forecast		 FY26
Forecast
EPS (cps) xxx - 1.6 3.0 xxx
DPS (cps) xxx 3.2 2.8 xxx
EPS Growth xxx N/A N/A xxx
DPS Growth xxx 6.7% - 12.5% xxx
PE Ratio xxx N/A 12.2 xxx
Dividend Yield xxx N/A 7.7% xxx
Div Pay Ratio(%) xxx N/A 93.3% xxx

Dividend yield today if purchased 3 years ago: 4.00%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 8.77

Estimated Dividend Growth
(Average Of Past Three Years)

  %

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 04/09 - ex-div 1.7c (franking 100%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2024 FactSet UK Limited. All rights reserved
Title 201920202021202220232024
EPS Basic xxxxxxxxxxxxxxx-1.6
DPS All xxxxxxxxxxxxxxx3.2
Sales/Revenue xxxxxxxxxxxxxxx416.6 M
Book Value Per Share xxxxxxxxxxxxxxx54.8
Net Operating Cash Flow xxxxxxxxxxxxxxx3.9 M
Net Profit Margin xxxxxxxxxxxxxxx1.68 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201920202021202220232024
Return on Capital Employed xxxxxxxxxxxxxxx1.67 %
Return on Invested Capital xxxxxxxxxxxxxxx1.34 %
Return on Assets xxxxxxxxxxxxxxx0.26 %
Return on Equity xxxxxxxxxxxxxxx1.67 %
Return on Total Capital xxxxxxxxxxxxxxx3.03 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx-25.8 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201920202021202220232024
Short-Term Debt xxxxxxxxxxxxxxx0 M
Long Term Debt xxxxxxxxxxxxxxx111 M
Total Debt xxxxxxxxxxxxxxx111 M
Goodwill - Gross xxxxxxxxxxxxxxx12 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx101 M
Price To Book Value xxxxxxxxxxxxxxx1.10

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201920202021202220232024
Capex xxxxxxxxxxxxxxx11.9 M
Capex % of Sales xxxxxxxxxxxxxxx2.85 %
Cost of Goods Sold xxxxxxxxxxxxxxx391 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx10 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx424 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

1.0

No. Of Recommendations

1
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Morgans

13/11/2024

1

Add

$0.58

58.90%

An unexpected negative claims hit of -$6.2m weighed on ClearView Wealth's 1Q AGM trading update, and Morgans now adopts a more conservative view on the NPAT margin profile into FY26.

Consequently, the broker's target falls to 58c from 81c, while the Add rating is kept given the stock is trading at approximately a -60% discount to Morgans' assessment of embedded value.

Management does not consider the elevated claims experience a long-term issue, noting claims in October had normalised, but Morgans prefers to wait and see whether the issue is a blip or a trend.

FORECAST
Morgans forecasts a full year FY25 dividend of 2.80 cents and EPS of 3.00 cents.
Morgans forecasts a full year FY26 dividend of 3.80 cents and EPS of 5.70 cents.
Access Stockbroker Research History >
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

1

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Taylor Collison

17/06/2024

2

Outperform

$0.90

146.58%

Taylor Collison points to Crescent Capital's recent sell-down of 11.2% of Clearview Wealth's shares which has improved liquidity, although a significant overhang remains.

For 3Q24, Clearview Wealth reported a 21% year-on-year increase in new business sales, marking the third consecutive year of growth in this quarter, highlights the broker.

The broker expects Clearview Wealth to maintain its dividend yield of approximately 5%.

Outperform rating and 90c target maintained.

FORECAST
Taylor Collison forecasts a full year FY25 dividend of 3.10 cents and EPS of 6.20 cents.
Access Extra Coverage Research History >

CVW STOCK CHART

FNArena News on CVW

1
Rudi’s View: Banks, WiseTech, Redox & Integral Diagnostics

Dec 19 2024 - Rudi's View
2
Rudi’s View: Best Buys & Smaller Cap Favourites

Dec 12 2024 - Rudi's View
3
Rudi’s View: In Santa We Trust (?)

Dec 05 2024 - Rudi's View
4
Rudi’s View: Trump Beneficiaries & TechOne

Nov 28 2024 - Rudi's View
5
Rudi’s View: The Importance Of ‘Quality’ Growth

Nov 21 2024 - Rudi's View

Latest Insurance News

1
ESG Focus: The Little Big Things – 21-11-2024

Nov 21 2024 - ESG Focus
2
New-Look Suncorp Ready To Rumble

Nov 14 2024 - Australia
3
Steadfast’s Long March

Jul 02 2024 - Australia
4
AUB Group Shares Poised For Break-Out

Jun 13 2024 - Technicals
5
SMSFundamentals: Older People Are Life Insurers’ Future Challenge

Oct 26 2023 - SMSFundamentals
6
Australian Insurers And The Weather

Oct 19 2023 - Feature Stories
7
Steadfast Group’s US Entry Full Of Promise

Oct 11 2023 - Australia
8
Pros And Cons Of Insurance Companies

Aug 02 2023 - Australia
9
Underlying Trends Positive For QBE Insurance

May 15 2023 - Australia
10
Rates Over Reinsurance For General Insurers 

Feb 01 2023 - Australia